Skip to content

CELU

Celularity Inc

NASDAQ · Healthcare · Biotechnology · US

$0.81
−1.02%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue18.7M26.6M54.2M22.8M18.0M
Cost of Revenue15.1M20.1M15.0M16.0M19.7M
Gross Profit3.6M6.5M39.2M6.8M(1.7M)
Operating Expenses
R&D Expense13.0M15.0M17.4M30.5M78.4M
SG&A Expense38.5M51.3M58.6M50.6M66.0M
General & Admin Expense38.5M51.3M58.6M50.5M65.9M
Selling & Marketing Expense——23.0K44.0K163.0K
Other Expenses1.5M1.5M1.6M118.0M(120.5M)
Total Operating Expenses52.9M67.8M77.6M199.0M23.9M
Cost and Expenses68.0M87.9M92.6M215.1M43.6M
Operating Income (EBIT)(49.3M)(61.3M)(38.4M)(192.3M)(25.6M)
Non-Operating
Interest Income197.0K262.0K331.0K320.0K365.0K
Interest Expense2.9M6.8M6.3M3.0M—
Net Interest Income(2.7M)(6.5M)(5.9M)(2.7M)365.0K
Other Non-Op Income/Expense3.5M(30.4M)(19.5M)(4.0M)39.8M
Non-Operating Income (excl Interest)(6.4M)23.7M13.3M983.0K122.7M
EBT (Pre-Tax Income)(45.9M)(91.7M)(57.9M)(196.3M)14.2M
Income Tax Expense3.0K3.0K—10.0K13.0K
Bottom Line
Net Income(45.9M)(91.7M)(57.9M)(196.3M)14.2M
Earnings from Cont. Ops(45.9M)(91.7M)(57.9M)(196.3M)14.2M
Earnings from Discont. Ops—————
Bottom Line Net Income(46.2M)(91.8M)(57.9M)(196.3M)14.2M
Per Share
Basic EPS($1.79)($3.59)($2.64)($11.02)$1.01
Diluted EPS($1.79)($3.59)($2.64)($11.02)$0.95
Revenue Per Share$0.64$1.04$2.48$1.28$1.28
Shares
Basic Shares Outstanding29.2M25.6M21.9M17.8M14.0M
Diluted Shares Outstanding29.3M25.6M21.9M17.8M15.0M
Profitability Metrics
EBITDA(36.2M)(77.7M)(43.7M)(183.9M)(138.8M)
D&A6.8M7.3M7.9M9.3M9.4M
EBIT(43.0M)(85.0M)(51.6M)(193.3M)(148.3M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026